Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fenoldopam to Prevent Renal Dysfunction in Indomethacin Treated Preterm Infants

NCT02620761 is registered in ClinicalTrials.gov with Medical College of Wisconsin as lead sponsor.

NCT NCT02620761
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02620761 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fenoldopam to Prevent Renal Dysfunction in Indomethacin Treated Preterm Infants
Lead sponsor
Medical College of Wisconsin
Phase
Phase 2/3
Overall status
Terminated
Start date
February 6, 2019
Completion date
January 31, 2020
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury (aki), patent ductus arteriosus (pda)